Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 447

1.

Reduction in gastroenteritis with the use of pentavalent rotavirus vaccine in a primary practice.

Bégué RE, Perrin K.

Pediatrics. 2010 Jul;126(1):e40-5. doi: 10.1542/peds.2009-2069. Epub 2010 Jun 29.

PMID:
20587671
2.

Active, population-based surveillance for severe rotavirus gastroenteritis in children in the United States.

Payne DC, Staat MA, Edwards KM, Szilagyi PG, Gentsch JR, Stockman LJ, Curns AT, Griffin M, Weinberg GA, Hall CB, Fairbrother G, Alexander J, Parashar UD.

Pediatrics. 2008 Dec;122(6):1235-43. doi: 10.1542/peds.2007-3378.

PMID:
19047240
3.

Effectiveness of pentavalent rotavirus vaccine in a large urban population in the United States.

Boom JA, Tate JE, Sahni LC, Rench MA, Hull JJ, Gentsch JR, Patel MM, Baker CJ, Parashar UD.

Pediatrics. 2010 Feb;125(2):e199-207. doi: 10.1542/peds.2009-1021. Epub 2010 Jan 18.

PMID:
20083525
4.

Burden of acute gastroenteritis hospitalizations and emergency department visits in US children that is potentially preventable by rotavirus vaccination: a probe study using the now-withdrawn rotashield vaccine.

Tate JE, Curns AT, Cortese MM, Weintraub ES, Hambidge S, Zangwill KM, Patel MM, Baggs JM, Parashar UD.

Pediatrics. 2009 Mar;123(3):744-9. doi: 10.1542/peds.2008-1200.

PMID:
19254997
5.

Effectiveness of an incomplete RotaTeq (RV5) vaccination regimen in preventing rotavirus gastroenteritis in the United States.

Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD.

Pediatr Infect Dis J. 2013 Mar;32(3):278-83. doi: 10.1097/INF.0b013e318275328f.

PMID:
23014356
6.

Effectiveness of the pentavalent rotavirus vaccine in preventing gastroenteritis in the United States.

Wang FT, Mast TC, Glass RJ, Loughlin J, Seeger JD.

Pediatrics. 2010 Feb;125(2):e208-13. doi: 10.1542/peds.2009-1246. Epub 2010 Jan 25.

PMID:
20100757
7.

Case-control study of the effectiveness of vaccination with pentavalent rotavirus vaccine in Nicaragua.

Mast TC, Khawaja S, Espinoza F, Paniagua M, Del Carmen LP, Cardellino A, Sánchez E.

Pediatr Infect Dis J. 2011 Nov;30(11):e209-15. doi: 10.1097/INF.0b013e31822a8527.

PMID:
21768920
8.

Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule.

Buttery JP, Lambert SB, Grimwood K, Nissen MD, Field EJ, Macartney KK, Akikusa JD, Kelly JJ, Kirkwood CD.

Pediatr Infect Dis J. 2011 Jan;30(1 Suppl):S25-9. doi: 10.1097/INF.0b013e3181fefdee. Erratum in: Pediatr Infect Dis J. 2011 Oct; 30(10):916.

PMID:
21183837
9.

Pentavalent rotavirus vaccine and prevention of gastroenteritis hospitalizations in Australia.

Field EJ, Vally H, Grimwood K, Lambert SB.

Pediatrics. 2010 Sep;126(3):e506-12. doi: 10.1542/peds.2010-0443. Epub 2010 Aug 23.

PMID:
20732946
10.

Effectiveness of pentavalent rotavirus vaccine against severe disease.

Staat MA, Payne DC, Donauer S, Weinberg GA, Edwards KM, Szilagyi PG, Griffin MR, Hall CB, Curns AT, Gentsch JR, Salisbury S, Fairbrother G, Parashar UD; New Vaccine Surveillance Network (NVSN)..

Pediatrics. 2011 Aug;128(2):e267-75. doi: 10.1542/peds.2010-3722. Epub 2011 Jul 18.

PMID:
21768317
11.

Routine laboratory testing data for surveillance of rotavirus hospitalizations to evaluate the impact of vaccination.

Patel MM, Tate JE, Selvarangan R, Daskalaki I, Jackson MA, Curns AT, Coffin S, Watson B, Hodinka R, Glass RI, Parashar UD.

Pediatr Infect Dis J. 2007 Oct;26(10):914-9.

PMID:
17901797
12.

Efficacy of the pentavalent rotavirus vaccine, RotaTeq® (RV5), between doses of a 3-dose series and with less than 3 doses (incomplete regimen).

Dennehy PH, Vesikari T, Matson DO, Itzler RF, Dallas MJ, Goveia MG, DiNubile MJ, Heaton PM, Ciarlet M.

Hum Vaccin. 2011 May;7(5):563-8. Epub 2011 May 1.

PMID:
21441783
13.

Summary of effectiveness and impact of rotavirus vaccination with the oral pentavalent rotavirus vaccine: a systematic review of the experience in industrialized countries.

Giaquinto C, Dominiak-Felden G, Van Damme P, Myint TT, Maldonado YA, Spoulou V, Mast TC, Staat MA.

Hum Vaccin. 2011 Jul;7(7):734-48. doi: 10.4161/hv.7.7.15511. Epub 2011 Jul 1. Review.

PMID:
21734466
14.

Rotavirus live, oral, pentavalent vaccine.

Tom-Revzon C.

Clin Ther. 2007 Dec;29(12):2724-37. doi: 10.1016/j.clinthera.2007.12.018. Review.

PMID:
18201590
15.

Efficacy of the pentavalent rotavirus vaccine, RotaTeq®, in Finnish infants up to 3 years of age: the Finnish Extension Study.

Vesikari T, Karvonen A, Ferrante SA, Ciarlet M.

Eur J Pediatr. 2010 Nov;169(11):1379-86. doi: 10.1007/s00431-010-1242-3. Epub 2010 Jun 18.

16.

Estimated burden of rotavirus-associated diarrhea in ambulatory settings in the United States.

Flores AR, Szilagyi PG, Auinger P, Fisher SG.

Pediatrics. 2010 Feb;125(2):e191-8. doi: 10.1542/peds.2008-1262. Epub 2010 Jan 25.

PMID:
20100749
17.

Hospitalizations associated with rotavirus gastroenteritis in the United States, 1993-2002.

Charles MD, Holman RC, Curns AT, Parashar UD, Glass RI, Bresee JS.

Pediatr Infect Dis J. 2006 Jun;25(6):489-93.

PMID:
16732145
18.

Universal mass vaccination against rotavirus gastroenteritis: impact on hospitalization rates in austrian children.

Paulke-Korinek M, Rendi-Wagner P, Kundi M, Kronik R, Kollaritsch H.

Pediatr Infect Dis J. 2010 Apr;29(4):319-23. doi: 10.1097/INF.0b013e3181c18434.

PMID:
19935446
19.

Development of a rotavirus vaccine: clinical safety, immunogenicity, and efficacy of the pentavalent rotavirus vaccine, RotaTeq.

Ciarlet M, Schödel F.

Vaccine. 2009 Dec 30;27 Suppl 6:G72-81. doi: 10.1016/j.vaccine.2009.09.107. Review.

PMID:
20006144
20.

Efficacy of pentavalent rotavirus vaccine in a high HIV prevalence population in Kenya.

Feikin DR, Laserson KF, Ojwando J, Nyambane G, Ssempijja V, Audi A, Nyakundi D, Oyieko J, Dallas MJ, Ciarlet M, Neuzil KM, Breiman RF.

Vaccine. 2012 Apr 27;30 Suppl 1:A52-60. doi: 10.1016/j.vaccine.2011.08.043.

PMID:
22520137

Supplemental Content

Support Center